CoChat

The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand

Open access

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Schistosomiasis is a debilitating tropical disease caused by infection with parasitic blood flukes. Approximately 260 million people are infected worldwide, underscoring the clinical and socioeconomic impact of this chronic infection. Schistosomiasis is treated with the drug praziquantel (PZQ), which has proved the therapeutic mainstay for over three decades of clinical use. However, the molecular target(s) of PZQ remain undefined. Here we identify a molecular target for the antischistosomal eutomer — (R) -PZQ — which functions as a partial agonist of the human serotoninergic 5HT 2B receptor. (R) -PZQ modulation of serotoninergic signaling occurs over a concentration range sufficient to regulate vascular tone of the mesenteric blood vessels where the adult parasites reside within their host. These data establish (R) -PZQ as a G-protein-coupled receptor ligand and suggest that the efficacy of this clinically important anthelmintic is supported by a broad, cross species polypharmacology with PZQ modulating signaling events in both host and parasite.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-02084-0

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Resolution of stereoselective (R)-PZQ interaction with human 5-HT2BR. Structures of the PZQ enantiomers: active, a antischistocidal (R)-PZQ (top, red) and b (S)-PZQ (bottom, blue). c Docking poses of R-PZQ (light red) and S-PZQ (light blue) in the human 5HT2BR. Both isomers of PZQ dock favorably within the orthosteric pocket of the 5HT2BR crystal structure (Protein Databank Code: 5TVN). The R-isomer shows a better predicted binding score by 0.6 kcal/mole partially due to a more favorable hydrogen bond with the backbone NH group of L209. d Displacement of 3H-LSD binding at human 5-HT2BR by racemic PZQ ((±)-PZQ 10 µM, purple), (R)-PZQ (5 µM, red) and (S)-PZQ (5 µM, blue) in the PDSP primary screen (n = 5 for all measurements). e Complete binding displacement curves for 3H-LSD displacement at human 5-HT2BR for SB206553 (black) and (±)-PZQ (purple, n = 5 for both ligands). f Functional Assays. Ca2+ flux assays showing responses from fluo-4 loaded Flp-In T-REx cells stably expressing 5-HT2AR, 5-HT2BR, or 5-HT2CR at indicated concentrations of (±)-PZQ (purple, top), (R)-PZQ (red, middle) and (S)-PZQ (blue, bottom; n = 3 for each concentration) in cells expressing 5-HT2AR, 5-HT2BR, or 5-HT2CR
Fig. 1 Resolution of stereoselective (R)-PZQ interaction with human 5-HT2BR. Structures of the PZQ enantiomers: active, a antischistocidal (R)-PZQ (top, red) and b (S)-PZQ (bottom, blue). c Docking poses of R-PZQ (light red) and S-PZQ (light blue) in the human 5HT2BR. Both isomers of PZQ dock favorably within the orthosteric pocket of the 5HT2BR crystal structure (Protein Databank Code: 5TVN). The R-isomer shows a better predicted binding score by 0.6 kcal/mole partially due to a more favorable hydrogen bond with the backbone NH group of L209. d Displacement of 3H-LSD binding at human 5-HT2BR by racemic PZQ ((±)-PZQ 10 µM, purple), (R)-PZQ (5 µM, red) and (S)-PZQ (5 µM, blue) in the PDSP primary screen (n = 5 for all measurements). e Complete binding displacement curves for 3H-LSD displacement at human 5-HT2BR for SB206553 (black) and (±)-PZQ (purple, n = 5 for both ligands). f Functional Assays. Ca2+ flux assays showing responses from fluo-4 loaded Flp-In T-REx cells stably expressing 5-HT2AR, 5-HT2BR, or 5-HT2CR at indicated concentrations of (±)-PZQ (purple, top), (R)-PZQ (red, middle) and (S)-PZQ (blue, bottom; n = 3 for each concentration) in cells expressing 5-HT2AR, 5-HT2BR, or 5-HT2CRCC BY · PubMed Central
Fig. 2 (R)-PZQ triggers Ca2+ release via 5-HT2BR. a Representative fluorescence traces from a single experiment where single cells loaded with fluo-4-AM in a HEK293 cell line prior to (top), or after (bottom) 5-HT2BR induction. Traces show fluorescence ratio following addition of indicated ligands (final concentrations (±)-PZQ (75 µM), 5-HT (100 nM) or ACh (100 µM)), or vehicle (DMSO, 0.05%). b Pseudocolored confocal images are displayed from the indicated times (‘1’–‘4’) on associated fluorescence traces as introduced in Fig. 1a. Scalebar, 80 µm. c Peak fluorescence ratio (F/F0, where ‘F’ represents fluorescence at peak and ‘F0‘ represents fluorescence at time = 0) from cumulative Ca2+ imaging after addition of vehicle, (±)-PZQ, 5-HT or ACh in uninduced (open bars) or induced cell lines (solid, hatched bars; n ≥ 3 independent inductions). Serotonergic antagonists (ritanserin (100 nM, final concentration), SB204741 (100 nM), or mesulergine (200 nM) were preincubated with induced cells prior to addition of (±)-PZQ (75 µM), 5-HT (10 nM), or ACh (100 µM). Data represent means ± s.e.m. of peak responses averaged from multiple cells (>20) from n ≥ 3 independent inductions. d Dose-response relationship for (±)-PZQ efficacy in cells induced for 5-HT2BR expression (n = 6 for each concentration). e Confocal Ca2+ imaging assays with (±)-PZQ and resolved enantiomers in uninduced (top row) and 5-HT2BR induced cell lines (bottom three rows). Experiments were performed with racemic PZQ ((±)-PZQ), and individual (S)-PZQ and (R)-PZQ stereoisomers (5 µM, final concentration). Scalebar, 80 µm. f Processed data set from experiments such as shown in e representing population mean ± s.e.m. (>20 cells) from n ≥ 3 independent inductions
Fig. 2 (R)-PZQ triggers Ca2+ release via 5-HT2BR. a Representative fluorescence traces from a single experiment where single cells loaded with fluo-4-AM in a HEK293 cell line prior to (top), or after (bottom) 5-HT2BR induction. Traces show fluorescence ratio following addition of indicated ligands (final concentrations (±)-PZQ (75 µM), 5-HT (100 nM) or ACh (100 µM)), or vehicle (DMSO, 0.05%). b Pseudocolored confocal images are displayed from the indicated times (‘1’–‘4’) on associated fluorescence traces as introduced in Fig. 1a. Scalebar, 80 µm. c Peak fluorescence ratio (F/F0, where ‘F’ represents fluorescence at peak and ‘F0‘ represents fluorescence at time = 0) from cumulative Ca2+ imaging after addition of vehicle, (±)-PZQ, 5-HT or ACh in uninduced (open bars) or induced cell lines (solid, hatched bars; n ≥ 3 independent inductions). Serotonergic antagonists (ritanserin (100 nM, final concentration), SB204741 (100 nM), or mesulergine (200 nM) were preincubated with induced cells prior to addition of (±)-PZQ (75 µM), 5-HT (10 nM), or ACh (100 µM). Data represent means ± s.e.m. of peak responses averaged from multiple cells (>20) from n ≥ 3 independent inductions. d Dose-response relationship for (±)-PZQ efficacy in cells induced for 5-HT2BR expression (n = 6 for each concentration). e Confocal Ca2+ imaging assays with (±)-PZQ and resolved enantiomers in uninduced (top row) and 5-HT2BR induced cell lines (bottom three rows). Experiments were performed with racemic PZQ ((±)-PZQ), and individual (S)-PZQ and (R)-PZQ stereoisomers (5 µM, final concentration). Scalebar, 80 µm. f Processed data set from experiments such as shown in e representing population mean ± s.e.m. (>20 cells) from n ≥ 3 independent inductionsCC BY · PubMed Central
Fig. 3 (R)-PZQ constricts mouse mesenteric vasculature. a Image of mesentery surrounding mouse intestine, showing blood vessel containing a schistosome worm-pair (inset). b Representative image of a surgically isolated piece of mouse mesenteric artery held under tension between two clamped wires. Scalebar, 1 mm. c Changes in tension triggered by varied manipulations. Left, sustained contraction of vessels in KPSS and 5-HT (10 µM). Right, tension in individual arteries incubated in the presence of vehicle (DMSO, open circle) or SB204741 (10 µM, closed circle), and challenged with (R)-PZQ (50 µM) or (S)-PZQ (50 µM). W, wash; complete media exchange. Preincubation of strips with SB204741 (10 µM) attenuated (R)-PZQ evoked vasoconstriction. d Cumulative data set from experiments reporting effects of ligands relative to KPS(S)-evoked contractile tension, concentrations of ligands: 5-HT (1 µM), (R)-PZQ (50 µM), (S)-PZQ (50 µM), SB204741 (10 µM). Replicate number for each measurement as indicated, where individual measurements reflect the response from a naïve artery isolated from different mice. Data are presented as mean ± s.d. Probability, p < 0.05 (*), p < 0.01 (**). e Schematic model (not to scale) depicting (R)-PZQ action on both parasite (contraction) and host vasculature (contraction, increased perfusion pressure) facilitating hepatic shift of worms
Fig. 3 (R)-PZQ constricts mouse mesenteric vasculature. a Image of mesentery surrounding mouse intestine, showing blood vessel containing a schistosome worm-pair (inset). b Representative image of a surgically isolated piece of mouse mesenteric artery held under tension between two clamped wires. Scalebar, 1 mm. c Changes in tension triggered by varied manipulations. Left, sustained contraction of vessels in KPSS and 5-HT (10 µM). Right, tension in individual arteries incubated in the presence of vehicle (DMSO, open circle) or SB204741 (10 µM, closed circle), and challenged with (R)-PZQ (50 µM) or (S)-PZQ (50 µM). W, wash; complete media exchange. Preincubation of strips with SB204741 (10 µM) attenuated (R)-PZQ evoked vasoconstriction. d Cumulative data set from experiments reporting effects of ligands relative to KPS(S)-evoked contractile tension, concentrations of ligands: 5-HT (1 µM), (R)-PZQ (50 µM), (S)-PZQ (50 µM), SB204741 (10 µM). Replicate number for each measurement as indicated, where individual measurements reflect the response from a naïve artery isolated from different mice. Data are presented as mean ± s.d. Probability, p < 0.05 (*), p < 0.01 (**). e Schematic model (not to scale) depicting (R)-PZQ action on both parasite (contraction) and host vasculature (contraction, increased perfusion pressure) facilitating hepatic shift of wormsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 70

Metadata

Authors
Chan, J. D., Cupit, P. M., Gunaratne, G. S., McCorvy, J. D., Yang, Y., Stoltz, K., Webb, T. R., Dosa, P. I., Roth, B. L., Abagyan, R., Cunningham, C., & Marchant, J. S.
Affiliations
  • University of Minnesota (US)
  • University of California San Diego (US)
  • University of North Carolina at Chapel Hill (US)
  • SRI International (US)
  • University of New Mexico (US)
Corresponding author
Marchant, Jonathan S.
Venue
Nature Communications
Published
2017-12-05
Volume
8
Issue
1
Pages
1910-1910
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2770931274
Cited by
69
References
35
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 19 · 2018: 16
FWCI
9.95
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • UNC Libraries
Funders
  • National Science Foundation (1615538)
  • National Institutes of Health (HHSN272201000005I, R21AI25821, HHSN-271-2013-00017-C, GM 088790)
  • National Institute of Mental Health (HHSN-271-2013-00017-C, R01MH061887, RO1MH61887)
  • National Institute of General Medical Sciences (P30GM110907, R01GM088790)
  • National Institute of Allergy and Infectious Diseases (F32AI124598, R21AI130642, R01AI087807, R21AI125821, HHSN272201000005I)
Topics
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Immunology and Microbiology › Parasitology › Helminth infection and control
Keywords
praziquantel, schistosomiasis, serotonin receptors, G protein-coupled receptors, anthelmintic mechanism of action, partial agonists, mesenteric vessels, vascular tone, host-parasite signaling, polypharmacology
MeSH terms
Animals, Anthelmintics, Cell Line, Computer Simulation, Female, Humans, Mesenteric Arteries, Mesenteric Veins, Myography, Praziquantel, Schistosoma mansoni, Schistosomiasis mansoni, Vasoconstriction, Receptor, Serotonin, 5-HT2B, Mice, Drug Partial Agonism, Serotonin 5-HT2 Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. https://app.cochat.ai/papers/10.1038/s41467-017-02084-0
The paper
Chan, J. D., Cupit, P. M., Gunaratne, G. S., McCorvy, J. D., Yang, Y., Stoltz, K., Webb, T. R., Dosa, P. I., Roth, B. L., Abagyan, R., Cunningham, C., & Marchant, J. S. (2017). The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. Nature Communications. https://doi.org/10.1038/s41467-017-02084-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.